Author:
Bruckert E.,Farnier M.,Ferrières J.
Subject
Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference74 articles.
1. Bongard V, Ruidavets JB, Arveiler D, et al. Three quarters of coronary heart disease is attributable to conventional modifiable cardiovascular risk factors in a French Cohort of 7161 men. XXIXth Annual Congress of the European Society of Cardiology. September 1-5, 2007, Vienna (Austria). Eur Heart J 2007;28(suppl.1):147 [Abstract A1080].
2. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
4. LaRosa JC, Grundy SM, Waters DD, et al; Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35.
5. Farnier M, Garnier P, Yau C, et al. Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholestérol HDL en Observationnel) French Survey. Int J Clin Pract 2006;60:1166-71.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献